Howard Robin
Vermögen: 4 Mio $ am 30.06.2026
Vermögen: 4 Mio $ am 30.06.2026
Howard W.
Robin is President, Chief Executive Officer & Director at Nektar Therapeutics since 2007.
Formerly, Mr. Robin was President, Chief Executive Officer & Director at Sirna Therapeutics, Inc. from 2001 to 2006.
From 1984 to 2001, held roles at Berlex, Inc., including Director-Business Planning & Development from 1987 to 2001 and Vice President & General Manager from 1991 to 2001.
Also served as Director at Acologix, Inc., Biotechnology Innovation Organization, and The Bay Area Bioscience Association.
Worked as Senior Associate at Arthur Andersen LLP.
Served as Trustee at Fairleigh Dickinson University.
Education includes an undergraduate degree from Fairleigh Dickinson University, conferred in 1974.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEKTAR THERAPEUTICS 0,16 % | 17.06.2026 | 55 073 ( 0,16 % ) | 4 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NEKTAR THERAPEUTICS | Vorstandsvorsitzender | 01.01.2007 |
| Unternehmen | Position | Ende |
|---|---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Vorstandsvorsitzender | 01.11.2006 |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Corporate Officer/Principal | - |
Berlex Laboratories, Inc. | Finanzdirektor/CFO | 01.01.1991 |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Health Technology |
Acologix, Inc.
Acologix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Bay Area Bioscience Association
The Bay Area Bioscience Association BiotechnologyHealth Technology Provides biomedical communities services | Health Technology |
Berlex Laboratories, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen